Literature DB >> 20602248

Molecular aspects of cyclophilins mediating therapeutic actions of their ligands.

Andrzej Galat1, Jacqueline Bua.   

Abstract

Cyclosporine A (CsA) is an immunosuppressive cyclic peptide that binds with a high affinity to 18 kDa human cyclophilin-A (hCyPA). CsA and its several natural derivatives have some pharmacological potential in treatment of diverse immune disorders. More than 20 paralogues of CyPA are expressed in the human body while expression levels and functions of numerous ORFs encoding cyclophilin-like sequences remain unknown. Certain derivatives of CsA devoid of immunosuppressive activity may have some potential in treatments of Alzheimer diseases, Hepatitis C and HIV infections, amyotrophic lateral sclerosis, congenital muscular dystrophy, asthma and various parasitic infections. Here, we discuss structural and functional aspects of the human cyclophilins and their interaction with various intra-cellular targets that can be under the control of CsA or its complexes with diverse cyclophilins that are selectively expressed in different cellular compartments. Some molecular aspects of the cyclophilins expressed in parasites invading humans and causing diseases were also analyzed.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20602248     DOI: 10.1007/s00018-010-0437-0

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  171 in total

1.  Lack of abundance of cytoplasmic cyclosporin A-binding protein renders free-living Leishmania donovani resistant to cyclosporin A.

Authors:  M Dutta; P Delhi; K M Sinha; R Banerjee; A K Datta
Journal:  J Biol Chem       Date:  2001-02-21       Impact factor: 5.157

Review 2.  The mitochondrial permeability transition as a target for neuroprotection.

Authors:  Bruce S Kristal; Irina G Stavrovskaya; Malini V Narayanan; Boris F Krasnikov; Abraham M Brown; M Flint Beal; Robert M Friedlander
Journal:  J Bioenerg Biomembr       Date:  2004-08       Impact factor: 2.945

Review 3.  Pharmacological targeting of catalyzed protein folding: the example of peptide bond cis/trans isomerases.

Authors:  F Edlich; G Fischer
Journal:  Handb Exp Pharmacol       Date:  2006

4.  Chaperone activity of Cyp18 through hydrophobic condensation that enables rescue of transient misfolded molten globule intermediates.

Authors:  Satish Babu Moparthi; Rikard Fristedt; Rajesh Mishra; Karin Almstedt; Martin Karlsson; Per Hammarström; Uno Carlsson
Journal:  Biochemistry       Date:  2010-02-16       Impact factor: 3.162

5.  Inhibitory effects of Actinidia polygama extract and cyclosporine A on OVA-induced eosinophilia and bronchial hyperresponsiveness in a murine model of asthma.

Authors:  Young-Cheol Lee; Seung-Hyung Kim; Young-Bae Seo; Seong-Soo Roh; Jang-Cheon Lee
Journal:  Int Immunopharmacol       Date:  2005-11-15       Impact factor: 4.932

6.  Molecular determinants of a native-state prolyl isomerization.

Authors:  Roman P Jakob; Franz X Schmid
Journal:  J Mol Biol       Date:  2009-02-20       Impact factor: 5.469

7.  A CD8 T cell-intrinsic role for the calcineurin-NFAT pathway for tolerance induction in vivo.

Authors:  Thomas Fehr; Carrie L Lucas; Josef Kurtz; Takashi Onoe; Guiling Zhao; Timothy Hogan; Casey Vallot; Anjana Rao; Megan Sykes
Journal:  Blood       Date:  2009-12-10       Impact factor: 22.113

8.  A large intrinsically disordered region in SKIP and its disorder-order transition induced by PPIL1 binding revealed by NMR.

Authors:  Xingsheng Wang; Shaojie Zhang; Jiahai Zhang; Xiaojuan Huang; Chao Xu; Weiwei Wang; Zhijun Liu; Jihui Wu; Yunyu Shi
Journal:  J Biol Chem       Date:  2009-12-09       Impact factor: 5.157

9.  Crystal structure of a complex between human spliceosomal cyclophilin H and a U4/U6 snRNP-60K peptide.

Authors:  Ulrich Reidt; Markus C Wahl; Dirk Fasshauer; David S Horowitz; Reinhard Lührmann; Ralf Ficner
Journal:  J Mol Biol       Date:  2003-08-01       Impact factor: 5.469

Review 10.  Host cell factors in HIV replication: meta-analysis of genome-wide studies.

Authors:  Frederic D Bushman; Nirav Malani; Jason Fernandes; Iván D'Orso; Gerard Cagney; Tracy L Diamond; Honglin Zhou; Daria J Hazuda; Amy S Espeseth; Renate König; Sourav Bandyopadhyay; Trey Ideker; Stephen P Goff; Nevan J Krogan; Alan D Frankel; John A T Young; Sumit K Chanda
Journal:  PLoS Pathog       Date:  2009-05-29       Impact factor: 6.823

View more
  18 in total

Review 1.  Advances in the current treatment of autoimmune hepatitis.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2012-04-03       Impact factor: 3.199

2.  Differential loss of prolyl isomerase or chaperone activity of Ran-binding protein 2 (Ranbp2) unveils distinct physiological roles of its cyclophilin domain in proteostasis.

Authors:  Kyoung-in Cho; Hemangi Patil; Eugene Senda; Jessica Wang; Haiqing Yi; Sunny Qiu; Dosuk Yoon; Minzhong Yu; Andrew Orry; Neal S Peachey; Paulo A Ferreira
Journal:  J Biol Chem       Date:  2014-01-08       Impact factor: 5.157

3.  Targeting the cyclophilin domain of Ran-binding protein 2 (Ranbp2) with novel small molecules to control the proteostasis of STAT3, hnRNPA2B1 and M-opsin.

Authors:  Kyoung-In Cho; Andrew Orry; Se Eun Park; Paulo A Ferreira
Journal:  ACS Chem Neurosci       Date:  2015-06-12       Impact factor: 4.418

4.  Synthesis of the C21-C34 fragment of antascomicin B.

Authors:  John M Hutchison; Andrew S Gibson; David T Williams; Matthias C McIntosh
Journal:  Tetrahedron Lett       Date:  2011-10-30       Impact factor: 2.415

Review 5.  Unraveling the role of peptidyl-prolyl isomerases in neurodegeneration.

Authors:  Melanie Gerard; Angélique Deleersnijder; Jonas Demeulemeester; Zeger Debyser; Veerle Baekelandt
Journal:  Mol Neurobiol       Date:  2011-05-07       Impact factor: 5.590

6.  The spliceosomal proteins PPIH and PRPF4 exhibit bi-partite binding.

Authors:  Caroline Rajiv; S RaElle Jackson; Simon Cocklin; Elan Z Eisenmesser; Tara L Davis
Journal:  Biochem J       Date:  2017-10-25       Impact factor: 3.857

Review 7.  From Drosophila to humans: reflections on the roles of the prolyl isomerases and chaperones, cyclophilins, in cell function and disease.

Authors:  Paulo A Ferreira; Andrew Orry
Journal:  J Neurogenet       Date:  2012-02-14       Impact factor: 1.250

Review 8.  Functional diversity and pharmacological profiles of the FKBPs and their complexes with small natural ligands.

Authors:  Andrzej Galat
Journal:  Cell Mol Life Sci       Date:  2012-12-08       Impact factor: 9.261

9.  Cyclophilin A binds to the viral RNA and replication proteins, resulting in inhibition of tombusviral replicase assembly.

Authors:  Nikolay Kovalev; Peter D Nagy
Journal:  J Virol       Date:  2013-10-02       Impact factor: 5.103

10.  Human nucleoporins promote HIV-1 docking at the nuclear pore, nuclear import and integration.

Authors:  Francesca Di Nunzio; Anne Danckaert; Thomas Fricke; Patricio Perez; Juliette Fernandez; Emmanuelle Perret; Pascal Roux; Spencer Shorte; Pierre Charneau; Felipe Diaz-Griffero; Nathalie J Arhel
Journal:  PLoS One       Date:  2012-09-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.